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The nucleocapsid protein (NC) of retroviruses is involved in viral RNA packaging and initiation of reverse transcription. NC also
mediates interactions between Gag and actin filaments. We found that residues at the amino terminus of NC are involved in
efficient actin binding. When alanine residues were substituted for the arginine and lysine at positions 10 and 11 of NC in HIVNL4-3,
these mutations decreased actin binding but had only a modest effect on virus infectivity. A similarly mutated virus based on the
HXB2 clone of HIV was not infectious. Mutational analysis of NL4-3 NC residues demonstrated that NC polymorphismsmodulated
the phenotype of NC mutations. Conservative amino acid differences between HXB2 and NL4-3 NCs were sufficient to explain theINTRODUCTION
All of the structural proteins of the core of the human
immunodeficiency virus (HIV) and other lentiviruses are
derived from a single polyprotein, Gag. Assembly of HIV
particles begins with aggregation of Gag polyprotein mol-
ecules at the plasma membrane. Activation of the viral
protease occurs in concert with release of immature viral
particles, resulting in the cleavage of Gag molecules into
the matrix (MA), capsid (CA), nucleocapsid (NC), and p6
proteins, as well as two small spacer peptides (p2 and p1)
initially interposed between CA and NC, and NC and p6,
respectively. Cleavage of Gag into these subunits leads to
the formation of infectious, mature virions with a cylindrical
core (Wills and Craven, 1991).
The subunits of Gag are themselves multifunctional.
The NC proteins of all lentiviruses include two zinc-
binding Cys–His boxes of the form CysX2CysX4HisX4Cys,
flanked by a series of basic residues (Darlix et al., 1995).
Alteration of these zinc-binding “knuckles” can cause
loss of packaging of genomic RNA and increased pack-
aging of spliced viral RNA and cellular mRNAs (Aldovini
and Young, 1990; Gorelick et al., 1999), while alterations
of the basic residues seem to affect the general ability to
bind RNA (Poon et al., 1996; Schmalzbauer et al., 1996).
Among other properties, the NC protein also promotes
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282the proper positioning of the tRNA primer for minus-
strand DNA synthesis and template switching during
reverse transcription (Guo et al., 2000). It may also con-
tribute to events in the integration of viral DNA (Carteau
et al., 1997, 1999). In addition, we and others have re-
cently determined that residues in NC allow Gag to bind
to filamentous actin (Rey et al., 1996; Liu et al., 1999; Wilk
et al., 1999). Although the biological significance of inter-
actions between Gag (or NC) and cytoskeletal filaments
remains unclear, it is conceivable that these interactions
play a role in virus assembly.
During studies of the role of the cytoskeleton in HIV
replication, we determined that interactions between NC
and F-actin involve the basic residues that precede the
amino-terminal Cys–His box of NC. We were surprised to
find that changing two basic residues in this domain to
alanines had little effect on the infectious titer of the NL4-3
strain of HIV, as this mutation had been previously de-
scribed to interfere with the packaging of genomic viral
RNA and to abrogate the infectivity of HIV reporter viruses
based on the HXB2 strain (Poon et al., 1996; Cimarelli et al.,
2000). In this report, we demonstrate that polymorphisms
seen in the NC domain can have a profound impact on the
infectivity of HIV-1 packaging mutants.
RESULTS
In vitro actin-binding properties of Gag proteins with
mutations in NCdifference in infectivity of viruses carrying the R10A and K11A
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munodeficiency virus.
Previous studies demonstrated that HIV-1 Gag protein
binds to actin filaments in vitro and in vivo (Ibarrondo etmutat
man im
on
al., 2001; Rey et al., 1996; Liu et al., 1999; Wilk et al., 1999).
Truncated Gag proteins lacking p1 and p6 retained sub-
stantial actin binding (Ibarrondo et al., 2001; Liu et al.,
1999; Wilk et al., 1999). In contrast, F-actin binding was
lost when Gag was further truncated to remove NC (Fig.
1). Actin-binding proteins are often rich in cationic amino
acids (Vandekerckhove and Vancompernolle, 1992). In an
effort to identify residues in NC that mediate Gag–actin
interactions, we therefore deleted 12 amino acids of NC
that precede the first Cys–His motif (NC 2-13); this
decreased the binding of Gag to F-actin approximately
twofold, from an average of 53 to 32%. Binding was
decreased to a comparable extent by substituting ala-
nine residues for the adjacent arginine and lysine resi-
dues found at NC positions 10 and 11 (R10A-K11A). Thus,
residues involved in actin binding were identified in the
first half of NC.
We analyzed the effect of the R10A-K11A mutations on
infectivity. These mutations were introduced into the in-
fectious molecular proviral clone pNL4-3 (Adachi et al.,
1986). ELISA measurements of HIV-1 capsid antigen
cells revealed no significant difference in the amount of
virus released from cells transfected with the pNL4-3 and
pNL4-3/R10A-K11A plasmids (1120  277 ng/ml versus
1222  362 ng/ml; not statistically significant by paired T
test analysis of data from 12 paired transfections).
The viral protein composition of these stocks was
analyzed by pelleting virions through 15% sucrose. West-
FIG. 1. F-actin binding of wild-type and mutant Gag proteins. (A) pGag S378 and pGag429 have stop codons placed after the last codon of the p2
and NC codons, respectively, to encode truncated Gag proteins. The first 12 codons of NC that precede the first zinc-binding Cys–His motif were
deleted in pGag/NC 2-13. pGag/NC R10A-K11A encodes Gag with alanines substituted for arginine–lysine residues. (B) NC point mutations and
deletions. The positions of the alanine substitution encoded in pGag/NC R10A-K11A and of the deleted amino acids in pGag/NC 2-13 are shown.
(C) In vitro translated wild-type and mutant Gag proteins were assayed for binding to F-actin. Values represent the fraction of total Gag
(pellet/supernatant  pellet) that icosedimented with F-actin during ultracentrifugation of binding mixtures. Gag proteins were produced in
reticulocyte lysates programmed with the plasmid indicated. Background (fraction of Gag that pelleted in binding mixtures to which F-actin was not
added) is subtracted. Results are the average of a minimum of three experiments.
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ern blot analysis of the pelleted virus showed that the
R10A-K11A mutations did not alter the virion content of
the 66- and 51-kDa reverse transcriptase proteins, the
31-kDa integrase protein, or NC relative to the HIV capsid
protein (CA) (Fig. 2). The infectious titer was assessed
using Magi cells (Kimpton and Emerman, 1992); the
R10A-K11A mutations decreased the viral titer approxi-
mately twofold (Fig. 3).
We concluded that the reduction in actin binding due
to the R10A-K11A mutations did not impair the assembly
or release of virus from cells and was associated with
only a small decrease in virus infectivity.
The effect of NC polymorphisms on the phenotype of
the R10A-K11A packaging mutant
The infectivity results observed with pNL4-3/R10A-
K11A were in striking contrast to data from earlier reports
in which the R10A-K11A mutations were introduced into
a reporter virus (p10-11) based on the HXB2 strain of
HIV-1 (Poon et al., 1996). In the background of HXB2,
these mutations not only diminished the encapsidation
of genomic RNA by two thirds, but also decreased virus
infectivity by more than 100-fold. Moreover, transfer of a
large fragment that contained the entire gag gene of
p10-11 into pNL4-3 also abrogated virus infectivity (Ci-
marelli et al., 2000). We hypothesized that other amino
acid differences that exist between HXB2 and NL4-3
were amplifying the effects of the R10A-K11A mutations.
As an initial step, we analyzed the infectivity of the
mutant pNL4-3/HX10-11. This chimeric plasmid was con-
structed to test the effect of the R10A-K11A mutations on
infectivity of HIV when they are presented in the back-
ground of the different NC amino acid sequence en-
coded by the pHXB2gpt (Fisher et al., 1985). Virus stocks
produced with pNL4-3/HX 10-11 were 20-fold lower in
titer than NL4-3 and about 8-fold lower than pNL4-3/
R10A-K11A (Fig. 3B). This reduction in virus titer corre-
lated with the relative virion content of viral RNA (Fig. 4,
lanes 1–3). Inspection of the amino acid sequences of
HXB2 and NL4-3 in the region encoded by the fragment
transferred into pNL4-3 revealed eight amino acid differ-
ences (Fig. 3A). Two conservative changes, an aspara-
gine to histidine change and an alanine to glycine
change, exist in the capsid domain (not shown). In the p2
spacer peptide of HXB2, a serine is found in place of a
proline found in NL4-3. The two strains differed at five
additional amino acid positions in NC. To determine the
influence of these p2 and NC polymorphisms on the
phenotype of the R10A-K11A mutants, the HXB2 amino
acids were introduced into the NL4-3 backbone. The
serine to proline mutation in the p2 spacer region and
the NC I1M and K3R mutations were introduced together
(NLp2SMR) and slightly reduced virus infectivity but not
genomic RNA packaging (Figs. 3 and 4). The infectivity of
NL4-3/R10A-K11A was not further decreased with the
addition of the SMR mutations (compare NL4-3/R10A-
K11A and SMR/R10A-K11A in Fig. 3).
Three additional mutants were made in which single
amino acid changes were added to the SMR/R10A-K11A
background, to reflect differences between HXB2 and
NL4-3 at NC positions 11, 24, and 26. Addition of the K26R
mutation did not appreciably lower the infectivity of the
SMR/R10A-K11A mutant of NL4-3. In contrast, adding the
T12I or I24T mutations caused slight, but reproducible
further reductions in the infectivity. Although it is difficult
to speculate on the structural changes resulting from
these mutations alone or in combination with each other,
we examined the effects of adding the I24T and K26R
mutations together, since these are contained in the first
zinc knuckle of NC. The infectivity of the SMR/R10A-
K11A-I24T-K26R mutant virus was only 5% of that of
NL4-3 and was comparable to that of NL4-3/HX 10-11.
There was a correlation between viral titer and RNA
encapsidation, as the SMR/R10A-K11A-I24T-K26R mutant
had the lowest level of RNA encapsidation of any of the
NL4-3 mutants (comparable to NL4-3/HX10-11).
In summary, stepwise mutagenesis of the NC domain
of NL4-3 restored the environment of HXB2 in which the
R10A-K11A mutations have very deleterious effects on
virus infectivity. In the context of the SMR/R10A-K11A
mutations, the presence of a threonine at position 24 had
the greatest impact of the single mutants studied on
virus phenotype. Addition of the K26R mutation further
impaired virus infectivity.
FIG. 2. Immunoblot analysis of proteins in virions. Wild-type NL4-3
and mutant (R10A-K11A) viruses released from transfected 293T cells
were purified by pelleting through a cushion of 15% sucrose and
disrupted in protein loading gel loading buffer. Reverse transcriptase
(RT), integrase (IN), capsid (CA), and nucleocapsid (NC) proteins were
detected by immunoblot. The results are representative of the analysis
of virus from three separate transfections.
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DISCUSSION
In previous studies, alanines were substituted system-
atically for basic amino acids in the NC domain of the
HXB2 clone of HIV, demonstrating that these cationic
residues play an important role in the viral RNA-binding
activity of NC (Poon et al., 1996). Mutation of the two
adjacent residues R10 and K11 of NC attenuated the
infectivity of HIV to a degree comparable to the reduction
of viral RNA packaging: the packaging of viral RNA was
reduced by threefold but infectivity was decreased sig-
nificantly more. In contemporaneous studies, these mu-
tations were introduced in NC during studies of Gag–
actin interactions. Surprisingly, the R10A-K11A mutations
had much less effect on the infectivity of the NL4-3 clone
of HIV, apparently due to conservative amino acid differ-
ences between it and HXB2. Simultaneously substituting
serine, methionine, and arginine residues for proline,
isoleucine, and lysine in p2 and the amino terminus of
NC might have been expected to significantly interfere
with RNA packaging and the assembly of infectious
virus. Instead, these combined mutations only marginally
affected infectivity. Although deletion of the p2 domain,
where the proline to serine change occurred, has a
profound effect on morphogenesis (Krausslich et al.,
1995), p2 may be unstructured and truly function as a
spacer between important structural motifs found in NC
and CA. While we did not specifically examine the impact
of the individual I1M and K3R changes, they appeared to
have little influence on the infectivity of virus containing
the R10A-K11A mutations.
In contrast, the I24T mutation had a significant impact
on virus infectivity, especially when combined with the
K26R change. It is difficult to predict why this might be
the case. Both are present in the first zinc knuckle of NC
and could be involved with interactions with nucleic
acids during virus assembly or reverse transcription.
FIG. 3. Conservative changes in NC amino acid sequence affect the infectivity of NL4-3. (A) Amino acid sequence of NL4-3, HXB2, and the mutant
viruses. (B) Virus titration in Magi cells. Each bar represents the average viral titer of virus stocks produced in at least three transfections. All data
are normalized relative to the stock of parental HIVNL4-3 produced in the same batch of transfections.
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However, the degree of genomic RNA packaging was not
a perfect predictor of virus infectivity in studies of NC
mutants (Poon et al., 1996) (Gorelick et al., 1999). Pre-
sumably, the loss of infectivity seen with some NC mu-
tants that effectively package viral RNA derives from the
loss of one or more other NC functions. We have not
examined the actin-binding properties of Gag proteins
containing the NC polymorphisms from HXB2, but it is
conceivable that actin binding is an additional significant
function of NC that is impaired by some of these
changes.
During preparation of this paper, Cimarelli and Luban
presented the results of similar studies in which they
examined the effects of the R10A-K11A mutations of NC
in the context of the HXB2 polymorphisms (Cimarelli and
Luban, 2001). They quantified genomic RNA encapsida-
tion by slot blot analysis and found only loose associa-
tion between viral RNA content and infectivity of the
R10-K11A mutant. However, they too found that the I24T
mutation further diminished the infectivity of the R10A-
K11A mutant of NL4-3. They also showed that this mu-
tation diminished RNA encapsidation of NL4-3/R10A-
K11A, while having little effect on encapsidation on its
own. In contrast, our data reveal the additional impact of
polymorphisms at other positions in NC (1, 3, 12, 26) on
the single cycle infectivity of the R10-K11A mutant.
Separate structural models have been developed for
NC bound to synthetic RNA molecules that correspond to
two stem loop structures found in HIV-1 genomic RNA
(SL2 and SL3) (De Guzman et al., 1998; Amarasinghe et
al., 2000). In both models, NC amino acids 3 to 11 form a
310 helix that packs against the N terminal zinc knuckle.
However, the intraprotein interactions differ in the two
models. Among these differences, in the NC-SL2 struc-
ture, the aromatic side chain of the proline at position 6
is buried between the side chains of V13 and I24, while
in the NC-SL3 structure it is largely exposed and packs
against I24. Moreover, the orientation of the two zinc
knuckles of NC relative to one another is different in the
two structures. These models demonstrate the flexibility
of NC and its adaptive nature. These properties may
have clinical significance if nucleocapsid targeting drugs
are successfully developed for the treatment of HIV in-
fection (De Clercq, 2000).
METHODS
Construction of plasmids
Site-directed mutagenesis was used to mutate the
nucleotide sequence of pGag (previously called pGem3Z-
Gag) (Rey et al., 1996), which contains the complete Gag
open reading frame of HIV-1NL4-3 (Adachi et al., 1986)
using previously published procedures (Krogstad and
Champoux, 1990). Using the oligonucleotide 5 GCT ACC
ATA ATG ATA TGT TTC AAT TGT GGC 3, the codons for
the 12 amino acids of NC that precede the first Cys–His
box were deleted to produce the vector pGag/NC2-13.
Similarly, missense mutations were introduced to pro-
duce vectors encoding Gag proteins in which alanine
residues substitute for positively charged amino acids
found preceding the first zinc finger of NC (R10 and K11)
(pGag/NC R10A-K11A). Site-directed mutagenesis was
also used to introduce stop codons in the NC and p1
coding domains, to produce plasmids (pGag S378 and
pGag S429) that encode truncated Gag proteins (Ibar-
rondo et al., 2001) (Fig. 1). The nucleotide sequence of
the mutations was verified by dideoxynucleotide se-
quencing. RNA was transcribed from these vectors and
FIG. 4. Relative genomic RNA content of virions determined by
RT–PCR. RNA samples from pelleted virions containing equal amounts
of viral p24 antigen were reverse transcribed and subjected to PCR
amplification in presence of [32P]dCTP. The intensity of a band corre-
sponding to the amplification of genomic RNA from mutated viruses
was compared to the intensity of bands produced by amplifying serially
diluted RNA from the wild-type parental virus NL4-3 (standards) and is
reported as percentage of the wild-type virus NL4-3. The top panel
shows the results of one representative experiment with a subset of the
mutant viruses. In the top panel, lanes are 1, NL4-3; 2, NL4-3/R10A-
K11A; 3, NL4-3/HX 10-11; 4, NLp2SMR; 5, SMR/R10A-K11A-T12I; 6,
SMR/R10A-K11A-I24T-K26R. The histogram reports the mean and stan-
dard error obtained from three independent experiments, each carried
out in triplicate.
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used to produce radiolabeled, truncated Gag proteins in
reticulocyte lysates following the manufacturer’s instruc-
tions (Promega, Madison, WI). pGag/NC R10A-K11A was
digested with SpeI and ApaI restriction endonucleases
to release a 503-bp fragment, which was ligated into
pNL4-3 (Adachi et al., 1986) to produce a proviral vector
with the NC R10A-K11A mutations (pNL4-3/R10A-K11A).
Other mutations were subsequently made using primer
overlap PCR mutagenesis (Ausubel et al., 1987). Using
pNL4-3 as the template, 1396s (5 GAG ACC ATC AAT
GAG GAA G 3) and 2081A (5 GCC TGT CTC TCA GTA
CAA TC3) as outside primers, and overlapping, internal
mutagenic primers, the proline residue in the p2 domain
and the isoleucine and lysine residues at NC positions 1
and 3 were changed to serine, methionine, and arginine.
The DNA product of this amplification was digested with
SpeI and ApaI, and the gel-purified 503-bp fragment
obtained from this digestion was ligated into pNL4-3.
This construct, pNLp2SMR, was used as the template for
subsequent rounds of mutagenesis in which additional
missense mutations were introduced in the NC coding
domain, as discussed in the text. The following mutants,
whose individual mutations are described in Fig. 3A,
were generated: SMR/R10A-K11A, SMR/R10A-K11A-T12I,
SMR/R10A-K11A-I24T, SMR/R10A-K11A-K26R, and SMR/
R10A-K11A-I24T-R26K. The sequences of the mutagenic
oligonucleotides will be made available on request. Also,
a SpeI–ApaI fragment from p10-11 (Poon et al., 1996) was
ligated into pNL4-3 to produce the plasmid pNL4/HX
10-11. The nucleotide sequences of the SpeI–ApaI frag-
ments were confirmed after cloning them into the NL4-3
proviral DNA, prior to transfection of cells to produce
virus stocks.
Actin cosedimentation assays
Binding assays to examine interactions between re-
combinant Gag protein and radiolabeled in vitro trans-
lated Gag protein and F-actin were performed as previ-
ously described (Rey et al., 1996) using 95 or 99% pure
rabbit skeletal muscle actin purchased from Cytoskele-
ton Inc. (Denver, CO). Briefly, radiolabeled protein from
reticulocyte lysates were incubated with in vitro polymer-
ized actin in 150 l of binding buffer at 0°C for 1 h and
then subjected to ultracentifugation (50,000 g for 60 min
in a Heraeus Biofuge (Hanau, Germany)). The superna-
tant was removed, and one-fifth volume of 5 SDS–
PAGE sample buffer was added. The pellets were dis-
rupted in 30 l of 5 SDS–PAGE sample buffer, to which
binding buffer (120 l) was subsequently added. Equal
volumes of these supernatant and pellet fractions were
separated by SDS–PAGE and quantified using a Phos-
phoimager SI and ImageQuant software (Molecular Dy-
namics, Sunnyvale, CA).
Virus preparation and infectivity assays
Virus stocks were produced by calcium phosphate
transfection of 293T cells, which were maintained in
Dulbecco’s modified Eagle’s medium. The infectious titer
was determined using cells that express -galactosi-
dase under the control of the HIV-LTR (Kimpton and
Emerman, 1992). Triplicate wells were infected with virus
stock containing 10 to 100 ng of HIV p24 antigen content.
The number of blue foci in three fields was counted in
each of three wells.
Viral protein analysis
Filtered supernatants of transfected 293T cells were
placed over 15% sucrose cushions (100 mM NaCl, 10 mM
Tris, pH 8.0) and centrifuged for 2 h at 150,000 g. Pelleted
virions were resuspended in PBS, and p24 viral capsid
antigen was measured by ELISA. Lysates containing
equal amounts of p24 were separated in SDS–PAGE gels
and transferred to membranes. The membrane was sep-
arated into four fragments for immunoblot analysis.
Pooled patient antiserum was used to detect the 24-kDa
CA protein. Integrase was detected using rabbit anti-
serum kindly provided by Dr. Duane Grandgenett. Re-
verse transciptase proteins were detected using a mono-
clonal antibody (Catalog No. 716) obtained from the AIDS
Research and Reference Reagent Program [Division of
AIDS, NIAID, NIH (supplied by Dr. Paul Yoshihara)]. NC
was detected using antiserum generously supplied by
Dr. Stuart LeGrice.
Particle-associated RNA analysis
Supernatants from transfected cells containing 50 ng
of viral p24 antigen were centrifuged to pellet the virions,
pellet-associated p24 was reevaluated, and viral RNA
was extracted from equal viral amounts. Quantitative
RT–PCR was performed on RNA samples according to a
previously described procedure (Poon et al., 1996).
Briefly, the viral pellet was resuspended in 0.5 ml of
TRIZOL (GIBCO BRL) containing 100 g/ml of yeast tRNA
as a carrier to monitor final RNA recovery. The RNA was
extracted with phenol–chloroform and precipitated with
ethanol. In order to eliminate contaminating transfection
or cellular DNA, the RNA was then treated with 20 units
of RQ1 DNase I (Promega) in the buffer recommended by
the manufacturer (40 mM Tris, pH 8, 10 mM NaCl, 6 mM
MgCl2, 10 mM CaCl2) in the presence of 40 units of
recombinant RNasin Ribonuclease Inhibitor (Promega)
for 1 h at 37°C. The DNase I was denatured with stop
solution provided by the manufacturer (20 mM EGTA, pH
8.0) and the RNA was precipitated with ethanol. DNase-
I-treated viral RNAs were resuspended in diethyl pyro-
carbonate-treated water and the yeast tRNA concentra-
tion was adjusted to 1 mg/ml. RNA samples were ob-
tained from three independent transfections of each
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construct. RNA samples corresponding to 6 ng of p24
were reverse transcribed in a 20-l reaction with Super-
script II Reverse Transcriptase (GIBCO/BRL) using a gag-
specific primer (HIVc1159: 5-GTCCTGTGTCAGCTGCT-
GCTTG-3). Two microliters of this reaction was sub-
jected to PCR with AmpliTaq DNA Polymerase (Perkin–
Elmer), in the presence of [32P]dCTP, employing the same
primer used in the RT reaction paired with an upstream
gag-specific primer (HIV910: 5-CTAGAACGATTCGCAGT-
TAATCC-3). The negative controls included a sample
from an RT–PCR reaction lacking input RNA and a RT–
PCR reaction with RNA extracted from a mock trans-
fected supernatant. A PCR reaction on an equivalent
amount of RNA, which did not undergo reverse transcrip-
tion, was carried out for each sample to exclude incom-
plete DNase I treatment. Equal volumes of RT–PCR or
PCR samples were subjected to polyacrylamide gel elec-
trophoresis and autoradiography. The intensity of each
band was quantitated using a Molecular Dynamics
PhosphorImager with ImageQuant software (Molecular
Dynamics).
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